Cuprimine Capsule
Pricing Report NDC 25010-705-15
Current Package Pricing Information
The latest wholesale acquisition cost for Cuprimine (NDC 25010-705-15) is $255.84785 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 31, 2015.
As a a human prescription drug provided by Bausch Health Us, Llc, this medication is distributed in a 100 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $255.84785 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
Since Dec 2013, the NADAC wholesale price for (NDC ) has moved within a range of $23.09959 to $255.84785 per EA. Over this 1 year and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$23.0996 - $255.8479
1,007.59% Variance
300.00%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jul 31, 2015 | $255.84785 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Jul 31, 2015 | $255.84785 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Jul 02, 2015 | $63.96196 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Jul 02, 2015 | $63.96196 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Nov 21, 2014 | $59.49950 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Nov 21, 2014 | $59.49950 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Jul 18, 2014 | $54.13967 | EA | C/I - Chain or Independent Pharmacy | Code 2 | B - Brand |
| Jul 18, 2014 | $54.13967 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Jul 18, 2014 | $54.13967 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| May 30, 2014 | $36.09311 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| May 30, 2014 | $36.09311 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Feb 28, 2014 | $28.87449 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Feb 28, 2014 | $28.87449 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Dec 18, 2013 | $23.09959 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Dec 18, 2013 | $23.09959 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
Pricing Methodology Legend
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
